Jeuk (South Korea)

Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer

Jae-Won Cho, Min Hee Hong, Sang‐Jun Ha et al. · Experimental & Molecular Medicine · 2020 · 276 citations · Full text

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of <i>EGFR</i> Exon 20 Insertion–Driven NSCLC

Jiyeon Yun, Soo‐Hwan Lee, Seok‐Young Kim et al. · Cancer Discovery · 2020 · 272 citations · Full text

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients

Hye Ryun Kim, Sang‐Jun Ha, Min Hee Hong et al. · Scientific Reports · 2016 · 257 citations · Full text

YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non–Small Cell Lung Cancer

Jiyeon Yun, Min Hee Hong, Seok‐Young Kim et al. · Clinical Cancer Research · 2019 · 124 citations · Full text

Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front–Mutant ROS1-Rearranged Non–Small Cell Lung Cancer

Mi Ran Yun, Dong Hwi Kim, Seok‐Young Kim et al. · Clinical Cancer Research · 2020 · 115 citations · Full text